Cargando…
Targeted therapy in gastrointestinal malignancies
Increased understanding of cancer pathogenesis has identified several pathways that serve as potential targets for novel targeted agents in development. The selection of targeted cancer therapy based on biomarkers has instigated a new era of personalized medicine and changed the way we practice onco...
Autores principales: | Chhatrala, Ravi, Thanavala, Yasmin, Iyer, Renuka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986534/ https://www.ncbi.nlm.nih.gov/pubmed/24737952 http://dx.doi.org/10.4103/1477-3163.127639 |
Ejemplares similares
-
High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
por: Lugade, Amit A, et al.
Publicado: (2013) -
Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients
por: Kalathil, Suresh Gopi, et al.
Publicado: (2020) -
Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
por: Kalathil, Suresh Gopi, et al.
Publicado: (2021) -
In vitro up-regulation of expression of GITR on human CD8+ cells
por: Thanavala, Yasmin
Publicado: (2009) -
Recent Advances in Targeted Therapies for Advanced Gastrointestinal Malignancies
por: C. Huynh, Jasmine, et al.
Publicado: (2020)